Pixium Vision announces participation in upcoming investor conferences in September 2022
Paris, France, September 6, 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris – FR0011950641; Mnemonic: ALPIX), a bioelectronics company developing innovative bionic vision systems to help patients who have lost their sight to live more independently, announces today that Management will attend the following investor conferences in September 2022:
- H.C. Wagner 24th Annual Global Investment Conference, September 12-14, NY & virtual
Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, will be attending virtually. Registration for the conference is open here.
- 9th Yearly HealthTech Investment Forum, September 20, Basel & September 26-30, Virtual
Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, in person and virtually. Registration for the conference is open here.
- LSI Europe ‘22 Emerging Medtech Summit21st September – 24, Hertfordshire, UK & Virtual
Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, will attend in person. Registration for the conference is open here.
- Sofinnova Healthcare CEO Days, September 28-30, Syracuse, Italy
Lloyd Diamond, Chief Executive Officer, will be present in person.
- MedInvest medical technologyAI & Digital Health Investor ConferenceSeptember 28-29, Virtual
Company presentations will be live streamed on Wednesday 28th and Thursday 29th September. There will be five full days of face-to-face partnering meetings from Monday 26th September to Friday 30th September. Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, will be attending virtually. Registration for the conference is open here.
To request a one-on-one meeting with Pixium Vision, please contact investors@pixium-vision.com.
Around Pixium Vision
Pixium Vision creates a world of bionic vision for people who have lost their sight and enables them to regain sight…
